Implementasi Cara Distribusi Obat Yang Baik terhadap Keluhan, Obat atau Bahan Obat Kembalian, Diduga Palsu dan Penarikan Kembali, Fasilitas Distribusi Berdasar Kontrak, Serta Dokumentasi di PT Kimia Farma Trading And Distribution Jakarta 2 = Implementation of Good Medicine Distribution Methods for Complaints, Returned Medicines or Drug Ingredients, Suspected of being Counterfeit and Recalled, Contract Based Distribution Facilities, and Documentation at PT Kimia Farma Trading and Distribut
Fitri Handayani;
Delly Ramadon, supervisor
(Fakultas Farmasi Universitas Indonesia, 2023)
|
|
Distribusi sediaan farmasi merupakan bagian yang sangat penting dalam pemerataan akses obat. Peredaran sediaan farmasi di Indonesia dikontrol oleh Badan Pengawas Obat dan Makanan (BPOM). Berdasarkan pada laporan Badan Pengawasan Obat dan Makanan (BPOM) di tahun 2018 terdapat 45% kasus peredaran obat di Indonesia yang berkaitan dengan penyimpangan distribusi obat ke pihak yang tidak berwenang. Proses distribusi yang menyimpang dapat menimbulkan berbagai resiko seperti kontaminasi, kerusakan maupun pemalsuan obat. Tujuan dari penulisan tugas khusus ini adalah untuk mengetahui dan memperoleh informasi terkait gambaran implementasi Cara Distribusi Obat yang Baik di Kimia Farma Trading and Distribution Jakarta 2 berdasarkan CDOB. Pengambilan data diperoleh dari hasil wawancara dan observasi langsung. Data berupa informasi tentang implementasi aspek-aspek CDOB berdasarkan Peraturan Badan Pengawas Obat dan Makanan Nomor 6 tahun 2020 berupa aspek Keluhan, Obat atau Bahan Obat Kembalian, Diduga Palsu dan Penarikan Kembali, Fasilitas Distribusi Berdasar Kontrak, serta Dokumentasi. Hasil yang diperoleh adalah aspek CDOB telah dilaksanakan oleh PT Kimia Farma Trading and Distribution Jakarta 2 sesuai dengan peraturan BPOM Tahun 2020. Distribution of pharmaceutical preparations is a very important part of equal access to medicines. The distribution of pharmaceutical preparations in Indonesia is controlled by the Food and Drug Supervisory Agency (BPOM). Based on reports from the Food and Drug Monitoring Agency (BPOM) in 2018, 45% of drug distribution cases in Indonesia were related to irregularities in drug distribution to unauthorized parties. Deviant distribution processes can cause various risks such as contamination, damage or counterfeiting of drugs. The purpose of writing this special assignment is to find out and obtain information regarding the implementation of Good Medicine Distribution Methods at Kimia Farma Trading and Distribution Jakarta 2 based on CDOB. Data collection was obtained from interviews and direct observation. Data in the form of information regarding the implementation of CDOB aspects based on Food and Drug Supervisory Agency Regulation Number 6 of 2020 in the form of aspects of Complaints, Returned Medicines or Medicinal Ingredients, Suspected Counterfeits and Recalls, Contract Based Distribution Facilities, and Documentation. The results obtained are that the CDOB aspect has been implemented by PT Kimia Farma Trading and Distribution Jakarta 2 in accordance with the 2020 BPOM regulations. |
 PR-Fitri Handayani3.pdf :: Unduh
|
| No. Panggil : | PR-PDF |
| Entri utama-Nama orang : | |
| Entri tambahan-Nama orang : | |
| Entri tambahan-Nama badan : | |
| Subjek : | |
| Penerbitan : | Depok: Fakultas Farmasi Universitas Indonesia, 2023 |
| Program Studi : |
| Bahasa : | ind |
| Sumber Pengatalogan : | LibUI ind rda |
| Tipe Konten : | text |
| Tipe Media : | computer |
| Tipe Carrier : | online resource |
| Deskripsi Fisik : | 40 pages : illustration |
| Naskah Ringkas : | |
| Lembaga Pemilik : | Universitas Indonesia |
| Lokasi : | Perpustakaan UI |
| No. Panggil | No. Barkod | Ketersediaan |
|---|---|---|
| PR-PDF | 16-24-62095548 | TERSEDIA |
| Ulasan: |
| Tidak ada ulasan pada koleksi ini: 9999920543648 |
